Click on image to open expanded view
Item No.
27822-3
DORMOSEDAN Rx
Availability:
-
In Stock
AutoShip & Save 40%
Size:
3 ml Gel
Product Description
DORMOSEDAN (detomidine hydrochloride) is a nonnarcotic, synthetic (alpha-2 adrenoreceptor agonist) equine sedative/analgesic that contains the active ingredient detomidine hydrochloride.
What is DORMOSEDAN?
DORMOSEDAN injectable and Gel (detomidine hydrochloride) is a nonnarcotic, synthetic equine sedative and analgesic that contains the active ingredient detomidine hydrochloride.
Who is DORMOSEDAN for?
Horses
Why use DORMOSEDAN?
DORMOSEDAN can be used safely for a variety of minor surgical and diagnostic procedures.
How does DORMOSEDAN work?
Use as a sedative and analgesic to facilitate minor surgical and diagnostic procedures in mature horses and yearlings.
Manufacturer:
Zoetis
Active Ingredients(s):
detomidine hydrochloride
How is DORMOSEDAN sold?
DORMOSEDAN is sold in 5 ml, 20ml injectable and Dormosedan gel 3ml. Dormosedan is sold by prescription only.
What are the side effects of DORMOSEDAN?
Horses treated with Dormosedan® exhibit hypertension. Bradycardia routinely occurs 1 minute after injection. The relationship between hypertension and bradycardia is consistent with an adaptive baroreceptor response to the increased pressure and inconsistent with a primary drug-induced bradycardia. Piloerection, sweating, salivation, and slight muscle tremors are frequently seen after administration. Partial transient penis prolapse may be seen. Partial AV and SA blocks may occur with decreased heart and respiratory rates. Urination typically occurs during recovery at about 45-60 minutes posttreatment, depending on dosage. Incoordination or staggering is usually seen only during the first 3-5 minutes after injection, until animals have secured a firm footing.
Because of continued lowering of the head during sedation, mucus discharges from the nose and, occasionally, edema of the head and face may be seen. Holding the head in a slightly elevated position generally prevents these effects.
OVERDOSAGE: Detomidine hydrochloride is tolerated in horses at up to 200 mcg/kg of body weight (10 times the low dosage and 5 times the high dosage). In safety studies in horses, detomidine hydrochloride at 400 mcg/kg of body weight administered daily for 3 consecutive days produced microscopic foci of myocardial necrosis in 1 of 8 horses.
What special precautions are there?
Not for use in horses intended for food. Not for human use. Keep out of reach of children
What to do if overdose?
Consult your nearest emergency animal hospital.
How can I store DORMOSEDAN?
Store at controlled room temperature 15°-30°C (59°-86°F) in the absence of light.
Overview
Use as directed by your veterinarian.
Main Ingredients
detomidine hydrochloride